Puricore Share Discussion Threads

[cockneyrebel] 07/11/2013 11:41

Breaking out on volume.

CR

[alexkb] 07/11/2013 07:37

new contract worth 3.5M over 4 years:


will be fully up/running by q2 14.

[cockneyrebel] 01/11/2013 11:54

Agree El1te - through resistance on that meaty director buy:

[somerset lad] 01/11/2013 10:00

£450k to go with £256k in September.

Looking at his bio (below), Mr Hegglin is well placed to identify an opportunity for profit.

Daniel Hegglin
Non-Executive Director
Danny Hegglin joined PuriCore in January 2013 as a Non-Executive Director. Mr. Hegglin is currently a partner at TT International, a Hong Kong investment management fund. There he is responsible for TT's hedge fund and Asian businesses. Prior to joining TT in 2009, he worked at Morgan Stanley in Europe and in Asia for 24 years. He began his career in London, moving to Switzerland and Germany to build their local equity businesses in the late 1980s; ran equity trading in London during the 1990s; and was on the boards of various industry groups. In 2004 he moved to Hong Kong as Head of Pan Regional Equity, and later ran the combined equity and fixed income businesses. In 2007 he was elected to Morgan Stanley's global operating committee. Mr. Hegglin serves on the Audit Committee.

[robbo35] 01/11/2013 07:23

Another big director buy!

[el1te] 28/10/2013 20:04

Was looking at PuriCore a couple of weeks back but held due to other opportunities. A key attraction was the technical outlook, and that has now been backed by the fundamentals. Very quick chart below of the formation that interested me.

[alexkb] 28/10/2013 17:58

i bought in at the last time it was 48p. was intending to sell today but the results are decent now im not sure. i think ill let it run a bit more to make a real profit, after buying/selling costs.

I do note that they state the margins are up because of the new equipment sales. i hope that doesnt mean that the next results will be down because of the lower margins on parts/consumables.

[brummy_git] 28/10/2013 09:49

Looks a very strong set of Q3 figures. If this pace of growth is maintained then the shares should go much, much higher

[sailing john] 28/10/2013 09:32

Bought in today

Impressive Q3 growth in retail

GL - SJ

[alexkb] 27/10/2013 23:49

results today. fingers crossed.

[twiggy2] 21/10/2013 12:49

Couple of buys have moved this up a little

[mathewawood] 15/10/2013 12:07

New Executive Director announced today. Expertise is in Healthcare, so obviously PURI see their Endoscopy and Wound Care products as the main growth drivers going forward. Backed up by the solid revenue from the US supermarkets.

[0rb1t] 11/10/2013 09:29

It looks like the story goes back to July 2009 when Puricore bought Labcaire from Misonix. Puricore won the dispute then and it looks like they secured a distribution deal with Misonix at the same time. You can imagine that Misonix would not be the best distribution partners having just lost a court case.

[soundbuy] 11/10/2013 07:52

Mixed bag of an RNS......

[johnward1234] 27/9/2013 10:31

hi eric,
it looks like lower targets have now been set for the puricore's new LITP for executives.
Under the preivous LTIP the share price had to reach £1.55 for their payouts to start.
puricore has now lowered this price target to 51.6p
Looks like to me a collapsing share price, but the executives payouts keep coming.Correct me if getting this wrong, but this threatened shareholder revolt is not working. )

[eric76] 27/9/2013 08:39

sounds like a reaction to the threatened shareholder revolt a while back..

[johnward1234] 27/9/2013 08:25

To me it sounds more like value creation for management.

[0rb1t] 27/9/2013 07:28

Value creation plan update sounds too much like management speak to me ;)



Hopefully a base price of 40.5p means they expect the price to be higher than this in the future.

On a side note, I see that the phrase "PuriCore's breakthrough wound therapy solution is used to treat chronic and acute wounds including diabetic ulcers and burns as well as atopic dermatitis as dermatologic treatment products." now appears as the second sentence. This could indicate it's importance in profit generation. I like the word "chronic" as this means on-going demand!

[makingmillions] 23/9/2013 14:48

Have bought some in here over the last week.Hopefully the outlook with the last results and the director buying should set a floor to the price around here.

[0rb1t] 14/9/2013 20:41

Interim result:



I like the way their have highlighted the key text. The Wound care business and concentrates have only just started contributing so should make good progress in H2.

[0rb1t] 14/9/2013 17:15

There seems to be several new companies that are going to create alternatives to pesticides. Is this a new market as a result of an EU Directive?

[eezymunny] 12/9/2013 09:25

Tx Orbit/mathew.

Get a feeling from the big dir buy, recent contract wins etc that this may well be a goodun. On the other hand they've grown top line from £7m to £30m and still don't turn a profit.

On balance just a tad too speculative for me at this stage. Possibly one that is always priced a bit too highly vs current progress for me to buy.

I sort of feel I may regret my caution. Good luck!

[mathewawood] 11/9/2013 21:47

EezyMunny - The big deal is:

At least break even this year and 2.35p EPS next (these look cautious broker estimates IMO), giving a forward P/E of 19, with good growth and margin improvement 5 years runnning. Not to mention the potential for new products i.e. Activita and the exponential growth of Wound Care.

The broker gives a stonking 107p price target.

Puricores products have been in the mkt place over 10y now and are a world away in refinement from the Terriss Consolidated Industries product.

P.S. Like your thread "Making Eezy Munny In The Stock Market" I too bought into ASH a true GASP (Growth at sensational price)